IL139307A0 - Triterpene compositions and methods for use thereof - Google Patents

Triterpene compositions and methods for use thereof

Info

Publication number
IL139307A0
IL139307A0 IL13930799A IL13930799A IL139307A0 IL 139307 A0 IL139307 A0 IL 139307A0 IL 13930799 A IL13930799 A IL 13930799A IL 13930799 A IL13930799 A IL 13930799A IL 139307 A0 IL139307 A0 IL 139307A0
Authority
IL
Israel
Prior art keywords
compounds
methods
mixtures
cells
triterpene compositions
Prior art date
Application number
IL13930799A
Other languages
English (en)
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL139307A0 publication Critical patent/IL139307A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
    • A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
    • A01H4/005—Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04—Plant cells or tissues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Environmental Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
IL13930799A 1998-05-19 1999-05-19 Triterpene compositions and methods for use thereof IL139307A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8599798P 1998-05-19 1998-05-19
US9906698P 1998-09-03 1998-09-03
PCT/US1999/011041 WO1999059578A1 (en) 1998-05-19 1999-05-19 Triterpene compositions and methods for use thereof

Publications (1)

Publication Number Publication Date
IL139307A0 true IL139307A0 (en) 2001-11-25

Family

ID=26773317

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13930799A IL139307A0 (en) 1998-05-19 1999-05-19 Triterpene compositions and methods for use thereof
IL139307A IL139307A (en) 1998-05-19 2000-10-26 Tritrenic glycosides extracted from ACACIA VICTORIAE

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139307A IL139307A (en) 1998-05-19 2000-10-26 Tritrenic glycosides extracted from ACACIA VICTORIAE

Country Status (13)

Country Link
US (8) US6444233B1 (xx)
EP (1) EP1079824B1 (xx)
JP (1) JP4860039B2 (xx)
KR (1) KR100785718B1 (xx)
CN (2) CN1307473A (xx)
AT (1) ATE522220T1 (xx)
AU (1) AU761879B2 (xx)
CA (1) CA2330916C (xx)
DK (1) DK1079824T3 (xx)
IL (2) IL139307A0 (xx)
NZ (2) NZ528940A (xx)
RU (1) RU2244547C2 (xx)
WO (1) WO1999059578A1 (xx)

Families Citing this family (127)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU761879B2 (en) 1998-05-19 2003-06-12 Research Development Foundation Triterpene compositions and methods for use thereof
WO2000048630A1 (en) 1999-02-17 2000-08-24 Csl Limited Immunogenic complexes and methods relating thereto
GB2367492A (en) * 1999-06-02 2002-04-10 Oxford Natural Products Plc Combination of glucosamine with herbal extracts of triptergium, ligustrum and erycibe
US7056491B2 (en) * 2000-11-08 2006-06-06 Wisconsin Alumni Research Foundation Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
AU2002218084A1 (en) 2000-11-09 2002-05-21 The Hospital For Sick Children Inhibitors of thromboxane formation and action
US20060148732A1 (en) * 2000-11-17 2006-07-06 Gutterman Jordan U Inhibition of NF-kappaB by triterpene compositions
JP2002322076A (ja) * 2001-02-26 2002-11-08 Oji Paper Co Ltd トリプシン阻害剤
US6777004B1 (en) * 2001-03-30 2004-08-17 Council Of Scientific & Industrial Research Composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same
US7736677B2 (en) 2001-06-20 2010-06-15 Metaproteomics, Llc Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
US7524824B2 (en) * 2003-09-04 2009-04-28 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
US7727561B2 (en) * 2001-08-31 2010-06-01 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
KR100464063B1 (ko) * 2001-11-21 2005-01-06 한국생명공학연구원 세포사멸 유도작용을 갖는 트리테르펜 화합물
BR0107262B1 (pt) * 2001-12-17 2014-04-22 Da Fonseca Clovis Orlando Pereira Composição farmacêutica inalatória
CA2471092A1 (en) * 2001-12-21 2003-07-10 Antigenics Inc. Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
TWI241916B (en) * 2001-12-28 2005-10-21 Jian-Shin Yang Method for producing nanometer of natural materials
CA2526943C (en) 2002-05-28 2011-08-09 The Hospital For Sick Children Compositions comprising hepoxilin analogs and their use in the treatment of cancer
AU2003264192A1 (en) * 2002-08-30 2004-03-19 Biopharmacopae Design International Inc. Plant extracts for treatment of angiogenesis and metastasis
US20090186837A1 (en) 2002-12-27 2009-07-23 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20090264377A1 (en) * 2002-12-27 2009-10-22 Linda Saxe Einbond Anti-neoplastic compositions comprising extracts of black cohosh
EP1635174A1 (en) * 2003-02-28 2006-03-15 Japan Science and Technology Agency Method of separating sugar from compound having glycoside bond, sugar separation system, sugar separation agent kit, standardized sample for sugar separation and assessment system
US7488753B2 (en) 2003-10-09 2009-02-10 Pacific Arrow Limited Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof
NZ546138A (en) * 2003-10-09 2009-12-24 Pacific Arrow Ltd Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
US8614197B2 (en) * 2003-10-09 2013-12-24 Pacific Arrow Limited Anti-tumor compounds with angeloyl groups
US20050095209A1 (en) * 2003-10-31 2005-05-05 Be! Products, Inc. Nail Application Containing Gotu Kola
US7388126B2 (en) * 2003-12-19 2008-06-17 Monsanto Technology Llc Use of nitric oxide modulators in Agrobacterium-mediated plant transformation
US8735558B2 (en) 2005-02-14 2014-05-27 Pacific Arrow Limited Blocking the migration or metastasis of cancer cells by affecting adhesion proteins and the uses of new compounds thereof
US9382285B2 (en) 2004-09-07 2016-07-05 Pacific Arrow Limited Methods and compounds for modulating the secretion or expression of adhesion proteins or angiopoietins of cells
JP4488852B2 (ja) * 2004-09-17 2010-06-23 味の素ゼネラルフーヅ株式会社 体内脂肪低減作用を有する組成物
WO2006034345A2 (en) * 2004-09-20 2006-03-30 Research Development Foundation Avicin-coated stents
US7727401B2 (en) * 2004-11-09 2010-06-01 Air Products And Chemicals, Inc. Selective purification of mono-terpenes for removal of oxygen containing species
CA2629529A1 (en) * 2004-11-18 2006-05-26 Biopharmacopae Design International Inc. Plant extracts and dermatological uses thereof
CA2595749A1 (en) * 2005-01-27 2006-08-03 Research Development Foundation Combination therapy with triterpenoid compounds and proteasome inhibitors
EP1866071A4 (en) * 2005-03-03 2013-04-24 Univ Indiana Res & Tech Corp PERMETHYLATION OF OLIGOSACCHARIDES
US7311050B2 (en) * 2005-04-19 2007-12-25 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
US8308075B2 (en) 2005-04-19 2012-11-13 Kamterter Products, Llc Systems for the control and use of fluids and particles
US7536962B2 (en) * 2005-04-19 2009-05-26 Kamterter Ii, L.L.C. Systems for the control and use of fluids and particles
US8586719B2 (en) 2005-04-27 2013-11-19 Pacific Arrow Limited Triterpenes for modulating gene expression and cell membrane, and as antiprotozoal agents
DK1889065T3 (da) * 2005-05-18 2013-09-02 Xoma Technology Ltd Metoder til diagnostisering og behandling af sygdomme med en autoimmun- og/eller inflammationskomponent
US8337851B2 (en) * 2005-05-18 2012-12-25 Novartis Ag Methods of monitoring the efficacy of anti-CD40 antibodies in treating a subject for a CD40-expressing cancer
US8853168B2 (en) * 2005-07-18 2014-10-07 Duke University Compositions for the reversible thioesterification of signaling proteins and methods of using same
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US7827042B2 (en) 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US7927787B2 (en) 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20080103746A1 (en) 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
WO2007086100A1 (ja) * 2006-01-24 2007-08-02 Ajinomoto General Foods, Inc. 血圧の降下作用及び／または上昇抑制作用を有する組成物およびこれを含有する飲食物
US20070202593A1 (en) * 2006-02-27 2007-08-30 Research Development Foundation Cell-Targeted IKB and Methods for the Use Thereof
WO2007118335A1 (en) 2006-04-19 2007-10-25 Evolva S.A. Hepoxilin analog enantiomers
US20070264298A1 (en) * 2006-05-10 2007-11-15 Stephen W. Lee Harvestwinner
JP4771882B2 (ja) * 2006-07-21 2011-09-14 味の素ゼネラルフーヅ株式会社 糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
EA018754B1 (ru) * 2006-08-03 2013-10-30 Онколоджи Рисерч Интернешнл Лимитед Способы и композиции для стимулирования активности противораковых терапий
EA016653B1 (ru) * 2006-08-03 2012-06-29 Онколоджи Рисерч Интернешнл Лимитед Способы и композиции для ингибирования ангиогенеза
US8822440B2 (en) * 2006-10-10 2014-09-02 Mayo Foundation For Medical Education And Research Inhibiting cyclin D polypeptides
WO2008115281A2 (en) * 2006-10-16 2008-09-25 Myriad Genetics, Inc. Compounds for treating viral infections
DE102006061517A1 (de) * 2006-12-18 2008-06-19 Eberhard-Karls-Universität Tübingen Universitätsklinikum Angioinhibin
WO2008094873A1 (en) * 2007-01-29 2008-08-07 Ligums John E Therapeutic bph composition
US20090274722A1 (en) * 2007-01-29 2009-11-05 Ligums John E Therapeutic Composition for the Treatment of BPH and ED
KR101163215B1 (ko) 2007-05-26 2012-07-06 한국생명공학연구원 헐떡이풀 추출물 또는 이로부터 분리된 트리테르펜화합물을 유효성분으로 함유하는 암 질환의 예방 및 치료용조성물
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
US7795311B2 (en) * 2007-10-15 2010-09-14 Pittsburg State University Methods and compositions for the management of soil-borne fungal diseases
CN101167787B (zh) * 2007-10-17 2011-06-22 江南大学 抑制血管生成的合欢属植物提取物的组合物及其制备和应用
EP2222339A2 (en) * 2007-11-26 2010-09-01 Research Development Foundation Use of avicins to deliver therapeutic and diagnostic agents
WO2009126926A2 (en) * 2008-04-11 2009-10-15 Bionovo, Inc. Anticancer methods employing extracts of gleditsia sinensis lam
US20120277308A1 (en) 2010-07-16 2012-11-01 Pacific Arrow Limited compounds for treating cancer and other diseases
US9499577B2 (en) 2009-07-16 2016-11-22 Pacific Arrow Limited Natural and synthetic compounds for treating cancer and other diseases
US9434677B2 (en) 2009-07-16 2016-09-06 Pacific Arrow Limited Natural and synthetic compounds for treating cancer and other diseases
WO2011034591A1 (en) * 2009-09-17 2011-03-24 New York University Methods of blocking ultraviolet radiation and promoting skin growth using terpenes and terpenoids
WO2011080579A2 (en) * 2009-12-30 2011-07-07 Himalaya Global Holdings Limited A herbal composition for inflammatory disorders
US8698496B2 (en) * 2010-09-20 2014-04-15 The General Hospital Corporation Method for two-dimensional correlation magnetic resonance spectroscopy
ES2568730T3 (es) * 2010-10-06 2016-05-04 The Board Of Trustees Of The University Of Arkansas Composiciones anti-biopelícula y métodos de uso
EP2529633B1 (de) * 2011-06-01 2014-08-06 Symrise AG Oral konsumierbare Zubereitungen umfassend bestimmte süß schmeckende Triterpene und Triterpenglycoside
US10226435B2 (en) 2011-06-07 2019-03-12 New York University Compositions and methods for restoring the stratum corneum and treating dermatological diseases
CN103889434B (zh) 2011-06-21 2017-02-15 Bvw控股公司 含有乳香酸的医疗装置
US20130269537A1 (en) 2012-04-16 2013-10-17 Eugenio Minvielle Conditioning system for nutritional substances
WO2013126730A1 (en) 2012-02-24 2013-08-29 Research Development Foundation Derivatives of avicin d and methods of making and using thereof
US8490862B1 (en) 2012-04-16 2013-07-23 Eugenio Minvielle Transformation system for nutritional substances
US20130269538A1 (en) 2012-04-16 2013-10-17 Eugenio Minvielle Transformation system for nutritional substances
US9541536B2 (en) 2012-04-16 2017-01-10 Eugenio Minvielle Preservation system for nutritional substances
US10219531B2 (en) 2012-04-16 2019-03-05 Iceberg Luxembourg S.A.R.L. Preservation system for nutritional substances
US9016193B2 (en) 2012-04-16 2015-04-28 Eugenio Minvielle Logistic transport system for nutritional substances
US9564064B2 (en) 2012-04-16 2017-02-07 Eugenio Minvielle Conditioner with weight sensors for nutritional substances
US9702858B1 (en) 2012-04-16 2017-07-11 Iceberg Luxembourg S.A.R.L. Dynamic recipe control
US9414623B2 (en) 2012-04-16 2016-08-16 Eugenio Minvielle Transformation and dynamic identification system for nutritional substances
US9121840B2 (en) 2012-04-16 2015-09-01 Eugenio Minvielle Logistic transport system for nutritional substances
US9460633B2 (en) 2012-04-16 2016-10-04 Eugenio Minvielle Conditioner with sensors for nutritional substances
US20140069838A1 (en) 2012-04-16 2014-03-13 Eugenio Minvielle Nutritional Substance Label System For Adaptive Conditioning
US8733631B2 (en) 2012-04-16 2014-05-27 Eugenio Minvielle Local storage and conditioning systems for nutritional substances
US9436170B2 (en) 2012-04-16 2016-09-06 Eugenio Minvielle Appliances with weight sensors for nutritional substances
US8550365B1 (en) 2012-04-16 2013-10-08 Eugenio Minvielle System for managing the nutritional content for nutritional substances
US9171061B2 (en) 2012-04-16 2015-10-27 Eugenio Minvielle Local storage and conditioning systems for nutritional substances
US9429920B2 (en) 2012-04-16 2016-08-30 Eugenio Minvielle Instructions for conditioning nutritional substances
US9072317B2 (en) 2012-04-16 2015-07-07 Eugenio Minvielle Transformation system for nutritional substances
US9080997B2 (en) 2012-04-16 2015-07-14 Eugenio Minvielle Local storage and conditioning systems for nutritional substances
US8851365B2 (en) * 2012-04-16 2014-10-07 Eugenio Minvielle Adaptive storage and conditioning systems for nutritional substances
US9528972B2 (en) 2012-04-16 2016-12-27 Eugenio Minvielle Dynamic recipe control
US9069340B2 (en) 2012-04-16 2015-06-30 Eugenio Minvielle Multi-conditioner control for conditioning nutritional substances
WO2014100700A1 (en) 2012-12-20 2014-06-26 Research Development Foundation Cytoprotective derivatives of avicin d and methods of making and using thereof
CN104147089A (zh) * 2013-05-15 2014-11-19 伽蓝（集团）股份有限公司 金合欢提取物、制取方法及其用途
CN104147088A (zh) * 2013-05-15 2014-11-19 伽蓝（集团）股份有限公司 金合欢提取物在抗衰老中的应用
TWI492751B (zh) * 2013-06-04 2015-07-21 Univ Kaohsiung Medical 柴胡皂苷製備之醫藥組合物、其用途及其製備方法
US10790062B2 (en) 2013-10-08 2020-09-29 Eugenio Minvielle System for tracking and optimizing health indices
KR101514145B1 (ko) * 2013-10-14 2015-04-21 동의대학교 산학협력단 마카에리움 쿠스피다툼 추출물을 유효성분으로 포함하는 항암 조성물
KR101523434B1 (ko) * 2013-10-14 2015-05-27 동의대학교 산학협력단 줄베르나디아 글로비플로라 추출물을 유효성분으로 포함하는 항암 조성물
RU2562592C2 (ru) * 2013-10-23 2015-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Дальневосточный государственный технический рыбохозяйственный университет" Способ получения масляного экстракта из голотурий, обладающего биологически активными свойствами (варианты)
RU2562595C2 (ru) * 2013-10-23 2015-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Дальневосточный государственный технический рыбохозяйственный университет" Способ получения продукта, обладающего биологически активными свойствами, из голотурий
RU2562581C1 (ru) * 2014-01-29 2015-09-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Дальневосточный государственный технический рыбохозяйственный университет" Способ получения биологически активного средства из голотурий, обладающего общеукрепляющими и иммуномодулирующими свойствами
CN105358220A (zh) * 2014-06-03 2016-02-24 高雄医学大学 柴胡皂苷制备的药物组合物、其用途及其制备方法
USD762081S1 (en) 2014-07-29 2016-07-26 Eugenio Minvielle Device for food preservation and preparation
CN105467059B (zh) * 2015-12-30 2017-10-24 云南理想药业有限公司 一种治疗血尿的中药组合物的质量检测方法
WO2019021030A1 (en) 2017-07-26 2019-01-31 Clr Chemisches Laboratorium Dr. Kurt Richter Gmbh TOPICAL COMPOSITIONS BASED ON PLANTS
EP3434256A1 (en) 2017-07-26 2019-01-30 CLR-Chemisches Laboratorium Dr. Kurt Richter GmbH Topical herbal compositions
KR102295179B1 (ko) 2017-09-14 2021-08-30 피닉스 바이오테크놀러지 인코포레이티드. 바이러스 감염 치료를 위한 방법 및 조성물
AU2018334467B2 (en) 2017-09-14 2022-10-20 Phoenix Biotechnology, Inc. Method and improved neuroprotective composition for treating neurological conditions
CN110680818A (zh) * 2018-07-06 2020-01-14 云南民族大学 丝石竹酸在制备镇痛药物中的应用
CN110089326A (zh) * 2019-03-08 2019-08-06 贵州民族大学 一种辅助剂及利用其提高马尾松抗病性能的方法
EP4009981B1 (en) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
MX2020009095A (es) 2020-03-31 2022-07-28 Phoenix Biotechnology Inc Metodo y composiciones para el tratamiento de infeccion por coronavirus.
RU2745401C1 (ru) * 2020-07-13 2021-03-24 Федеральное государственное бюджетное учреждение науки Федеральный исследовательский центр "Институт биологии южных морей имени А.О. Ковалевского РАН" (ФИЦ ИнБЮМ) Способ индукции секреции биологически активных соединений у рапаны rapana venosa val.
CN111875662B (zh) * 2020-08-19 2022-08-16 中国人民解放军空军军医大学 一种美花铁线莲茎化学提取物的提取方法和应用
CN112245416A (zh) * 2020-11-17 2021-01-22 广西馨海药业科技有限公司 Pinnatifolone A在制备具有镇静、催眠作用药物中的应用及药物组合物
CN115843692B (zh) * 2022-12-29 2023-09-29 浙江省农业科学院 一种大花葱组织培养方法
CN116671440B (zh) * 2023-06-20 2024-05-03 江苏农林职业技术学院 一种丝瓜下胚轴离体再生方法及培养基配制
CN117653603B (zh) * 2023-10-16 2024-09-24 深圳市罗湖区人民医院 一种单萜香豆素衍生物纳米制剂及其制备方法和应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070623A (en) 1957-07-16 1962-12-25 Biorex Laboratories Ltd Pharmacological compounds
US3070624A (en) 1960-03-04 1962-12-25 Biorex Laboratories Ltd Glycyrrhetinic acid dialkylaminoalkyl esters
GB1255098A (en) 1969-07-28 1971-11-24 Biorex Laboratories Ltd Derivatives of glycyrrhetinic acid
US3814766A (en) 1971-11-03 1974-06-04 Pfizer 11-deoxoglycyrrhetinic acid piperazides useful as antiulcer agents
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4452901A (en) 1980-03-20 1984-06-05 Ciba-Geigy Corporation Electrophoretically transferring electropherograms to nitrocellulose sheets for immuno-assays
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4526714A (en) 1982-12-13 1985-07-02 Cordis Europa N.V. Conjugates of anticoagulant and protein
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
US5221605A (en) 1984-10-31 1993-06-22 Igen, Inc. Luminescent metal chelate labels and means for detection
US5310687A (en) 1984-10-31 1994-05-10 Igen, Inc. Luminescent metal chelate labels and means for detection
US5049388A (en) 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4975369A (en) 1988-04-21 1990-12-04 Eli Lilly And Company Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen
US5183756A (en) 1988-08-19 1993-02-02 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibody (D612) having selective reactivity for gastrointestinal caricinomas and method for employing the same
CA2064194A1 (en) 1989-07-27 1991-01-28 Nelson Teng Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines
US5242813A (en) 1990-10-12 1993-09-07 The United States Of America As Represented By The Department Of Health And Human Services Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors
JPH0673084A (ja) * 1992-08-27 1994-03-15 Shiratori Seiyaku Kk グリコシド及びこれを含有する抗肝炎剤
ATE220327T1 (de) 1992-09-29 2002-07-15 Inhale Therapeutic Syst Pulmonale abgabe von aktiven fragmenten des parathormons
JP3222672B2 (ja) * 1993-12-16 2001-10-29 三井農林株式会社 タンパク質合成阻害剤
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
EP1167377B2 (en) 1994-07-15 2012-08-08 University of Iowa Research Foundation Immunomodulatory oligonucleotides
KR0164266B1 (ko) 1996-02-22 1999-01-15 오오니시 쿠니히로 인삼사포닌 장내세균 대사물 및 이를 유효성분으로하는 제암제제
CA2281838A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders
AU753688B2 (en) 1997-03-10 2002-10-24 Ottawa Civic Loeb Research Institute Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
DE69838294T2 (de) 1997-05-20 2009-08-13 Ottawa Health Research Institute, Ottawa Verfahren zur Herstellung von Nukleinsäurekonstrukten
AU761879B2 (en) * 1998-05-19 2003-06-12 Research Development Foundation Triterpene compositions and methods for use thereof

Also Published As

Publication number Publication date
US8324177B2 (en) 2012-12-04
NZ507791A (en) 2003-12-19
US7985435B2 (en) 2011-07-26
US20030054052A1 (en) 2003-03-20
US6962720B2 (en) 2005-11-08
US7105186B2 (en) 2006-09-12
EP1079824A4 (en) 2008-03-12
AU761879B2 (en) 2003-06-12
IL139307A (en) 2012-12-31
EP1079824A1 (en) 2001-03-07
US20100189824A1 (en) 2010-07-29
US20030039705A1 (en) 2003-02-27
CA2330916A1 (en) 1999-11-25
NZ528940A (en) 2005-02-25
CA2330916C (en) 2011-04-05
ATE522220T1 (de) 2011-09-15
WO1999059578A1 (en) 1999-11-25
RU2244547C2 (ru) 2005-01-20
EP1079824B1 (en) 2011-08-31
CN102274272A (zh) 2011-12-14
CN1307473A (zh) 2001-08-08
JP4860039B2 (ja) 2012-01-25
US20060073222A1 (en) 2006-04-06
US20030203049A1 (en) 2003-10-30
KR100785718B1 (ko) 2007-12-18
DK1079824T3 (da) 2011-11-21
US6746696B2 (en) 2004-06-08
KR20010034867A (ko) 2001-04-25
US20110294752A1 (en) 2011-12-01
US7670632B2 (en) 2010-03-02
US20030031738A1 (en) 2003-02-13
JP2002515430A (ja) 2002-05-28
US6689398B2 (en) 2004-02-10
US6444233B1 (en) 2002-09-03
AU4087199A (en) 1999-12-06

Similar Documents

Publication Publication Date Title
IL139307A0 (en) Triterpene compositions and methods for use thereof
AP2004003103A0 (en) Controlled synthesis of ziprasidone and compositions thereof
DE60038038D1 (en) Phosphonatverbindungen
GB0129260D0 (en) Pharmaceutical compositions and their uses
PL367682A1 (en) Dolastatin 10 derivatives
HK1048990A1 (en) Novel compounds.
PL344861A1 (en) Trazinic angiogenesis inhibitiors
PL366198A1 (en) Novel compounds
WO2001056552A3 (en) Farnesyl protein transferase inhibitors for treating breast cancer
WO2000051548A3 (en) COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM)
BG102673A (en) Mixtures produced from grains of eugenia jambolana lamarck, their preparation and application and some of their components as medicinal forms
MXPA01008347A (es) Compuestos quimicos.
AU1022999A (en) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
ZA200000724B (en) 6-substituted 3-methyloct-6-enols.
WO1999056736A3 (en) Apoptosis-inducing compounds
IL160659A0 (en) Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
DE69929802D1 (en) Lta4 hydrolase-hemmer
IL150082A (en) Unsaturated 14,15 - cyclopropane
WO2023215032A3 (en) Potent anti-cancer cyclotides
ES2002019A6 (es) Procedimiento de preparacion de un nuevo derivado del tiocromano
UA86393C2 (ru) Производные фениламино-1н-имидазола и фармацевтическая композиция, которая их содержит
DK1242445T3 (da) 14, 15-Cycolopropanosteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling og farmaceutiske sammensætnining indeholdende disse forbindelser